Ibutilide Fumarate - CAS 122647-32-9
Catalog number: 122647-32-9
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
(C20H36N2O3S)2.C4H4O4
Molecular Weight:
885.23
COA:
Inquire
Targets:
Calcium Channel
Description:
Ibutilide Fumarate is a Class III antiarrhythmic agent that is indicated for acute cardioconversion of atrial fibrillation and atrial flutter of a recent onset to sinus rhythm by induction of slow inward sodium current, which prolongs action potentia
Purity:
>98%
Synonyms:
U-70226E
MSDS:
Inquire
InChIKey:
PCIOHQNIRPWFMV-WXXKFALUSA-N
InChI:
InChI=1S/2C20H36N2O3S.C4H4O4/c2*1-4-6-7-8-9-16-22(5-2)17-10-11-20(23)18-12-14-19(15-13-18)21-26(3,24)25;5-3(6)1-2-4(7)8/h2*12-15,20-21,23H,4-11,16-17H2,1-3H3;1-2H,(H,5,6)(H,7,8)/b;;2-1+
Canonical SMILES:
CCCCCCCN(CC)CCCC(C1=CC=C(C=C1)NS(=O)(=O)C)O.CCCCCCCN(CC)CCCC(C1=CC=C(C=C1)NS(=O)(=O)C)O.C(=CC(=O)O)C(=O)O
1.Increasing gap junction coupling suppresses ibutilide-induced torsades de pointes.
Ruan L1, Quan X1, Li L1, Bai R2, Ni M1, Xu R1, Zhang C1. Exp Ther Med. 2014 May;7(5):1279-1284. Epub 2014 Mar 4.
Drug-induced torsades de pointes (TdP) is common with class III antiarrhythmic drugs. Increased transmural dispersion of repolarization (TDR) contributes significantly to the development of TdP. Gap junctions play an important role in maintaining TDR in long QT syndrome. The present study examined the effect of a gap junction enhancer, antiarrhythmic peptide 10 (AAP10), on ibutilide-induced TdP. Coronary-perfused rabbit ventricular wedge preparations were used to evaluate the effect of AAP10 on ibutilide-induced arrhythmia. Transmural electrocardiograms and action potentials were recorded simultaneously. Early afterdepolarizations (EADs), R-on-T extrasystole, TdP and changes in Tpeak-end (Tp-e) and the Tp-e/QT ratio were observed. Changes in the levels of non-phosphorylated connexin 43 (Cx43) were measured by immunoblotting. Compared with those in the control group, the QT interval, Tp-e/QT and incidence rates of EAD and TdP increased with augmented dephosphorylation in the ventricular wedge preparations perfused with ibutilide under conditions of hypokalemia and hypomagnesemia.
2.Investigation of the antifibrillatory drug interactions between Amiodarone and Ibutilide in isolated, perfused Rabbit hearts.
Almotrefi AA1, Bukhari IA1, Alhumayyd MS1. Fundam Clin Pharmacol. 2015 Dec;29(6):553-7. doi: 10.1111/fcp.12141. Epub 2015 Sep 10.
In view of the reliability of the serial-shock method of measuring ventricular fibrillation threshold (VFT) in quantitatively assessing the antifibrillatory potency of many anti-arrhythmic drugs and the alarming reports of the proarrhythmic effects of several anti-arrhythmic agents, it was decided to use the above technique to study the possible interactions that may occur when anti-arrhythmic drugs from different classes are combined. Hearts isolated from New Zealand white rabbits of either sex weighing 1.5-2 kg were perfused by the Langendorff method with McEwen's solution. In six hearts, measurement of VFT was made in the absence of any drug throughout the experiments. Perfusion with either amiodarone or ibutilide produced significant, dose-dependent increase in VFT. In addition, there was no significant difference in the increase in VFT produced by the combined infusion of 1 μmol of amiodarone and 0.01 μmol of ibutilide and the summation of the increases produced by the separate infusion of these two concentrations.
3.The modified stepwise ablation guided by low-dose ibutilide in chronic atrial fibrillation trial (The MAGIC-AF Study).
Singh SM1, d'Avila A2, Kim YH3, Aryana A4, Mangrum JM5, Michaud GF6, Dukkipati SR7, Barrett CD8, Heist EK9, Parides MK7, Thorpe KE10, Reddy VY11. Eur Heart J. 2016 Feb 4. pii: ehw003. [Epub ahead of print]
AIMS: Complex fractionated atrial electrograms (CFAE) are targeted during persistent atrial fibrillation (AF) ablation. However, many CFAE sites are non-specific resulting in extensive ablation. Ibutilide has been shown to reduce left atrial surface area exhibiting CFAE. We hypothesized that ibutilide administration prior to CFAE ablation would identify sites critical for persistent AF maintenance allowing for improved procedural efficacy and long-term freedom from atrial arrhythmias.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Calcium Channel Products


CAS 129198-88-5 Autocamtide 2

Autocamtide 2
(CAS: 129198-88-5)

Autocamtide 2 is a highly selective synthetic peptide substrate of calcium/calmodulin-dependent protein kinase II (CaMKII). It can be used in the CaMKII activit...

CAS 125697-93-0 Lavendustin C

Lavendustin C
(CAS: 125697-93-0)

Lavendustin C, also known as HDBA and NSC 666251, inhibits Ca2+/CaMKII (calmodulin kinase II) (IC50=0.2 μM), EGFR tyrosine kinase (IC50=44 nM) and SRC (IC50=0.5...

CAS 248922-46-5 PD0176078

PD0176078
(CAS: 248922-46-5)

PD0176078 is a novel N-type calcium channel blocker.

CAS 152-11-4 Verapamil HCl

Verapamil HCl
(CAS: 152-11-4)

Verapamil HCl is an L-type calcium channel blocker that is a class IV anti-arrhythmia agent.

CAS 120934-96-5 FPL 64176

FPL 64176
(CAS: 120934-96-5)

FPL 64176 is a potent L-type Ca2+ channel activator (EC50 = 16 nM) displaying 40-fold potency against Bay K 8644 as a positive inotrope in guinea pig atria.

CAS 79700-61-1 Dopropidil

Dopropidil
(CAS: 79700-61-1)

Dopropidil, also called as ORG 30701, is a cardioactive drug to be classified as a calcium antagonist with combined class I and class VI antiarrhythmic properti...

CAS 484598-35-8 ProTx I

ProTx I
(CAS: 484598-35-8)

ProTx I, a toxin that was originally isolated from the venom of Thrixopelma pruriens (Peruvian green velvet tarantula), blocks native mouse CaV3.1 channel and r...

CAS 1841-19-6 Fluspirilene

Fluspirilene
(CAS: 1841-19-6)

Fluspirilene, with antipsychotic activity, is a non-competitive antagonist of agonist-activated L-type calcium channels (IC50 = 0.03 µM). Fluspirilene is also a...

CAS 111011-53-1 EFONIDIPINE HCL

EFONIDIPINE HCL
(CAS: 111011-53-1)

The hydrochloride salt form of Efonidipine which could be effective in the treatment of cardiovascular disease as a blocker of T-type and L-type calcium channel...

CI 951
(CAS: 126661-07-2)

CI 951 is a dihydronaphthyridine Ca2+ channel antagonist and it may be applicated for the treatment of focal cerebral ischemia. CI 951 has potential as a cerebr...

CAS 111011-63-3 EFONIDIPINE

EFONIDIPINE
(CAS: 111011-63-3)

Efonidipine could be effective in the treatment of cardiovascular disease as a blocker of T-type and L-type calcium channels. It could also present as the hydro...

CAS 116308-56-6 Watanipidine monohydrochloride

Watanipidine monohydrochloride
(CAS: 116308-56-6)

Watanipidine, also called as AE 0047 or Calbren, is a calcium channel antagonist.

OPC 13463
(CAS: 73372-63-1)

OPC 13463 is one of the metabolites of pranidipine. Pranidipine is a long acting calcium channel antagonist of the dihydropyridine group.

CAS 122647-32-9 Ibutilide Fumarate

Ibutilide Fumarate
(CAS: 122647-32-9)

Ibutilide Fumarate is a Class III antiarrhythmic agent that is indicated for acute cardioconversion of atrial fibrillation and atrial flutter of a recent onset ...

CAS 1346233-68-8 ML 218 hydrochloride

ML 218 hydrochloride
(CAS: 1346233-68-8)

ML 218 hydrochloride is a T-type calcium channel inhibitor with IC50 values of 270 nM for Cav3.3 and 310 nM for Cav3.2. It has potential applications for the tr...

CAS 145224-99-3 CALP1

CALP1
(CAS: 145224-99-3)

CALP1 is a cell-permeable calmodulin (CaM) agonist binding to the EF-hand/Ca2+-binding site and activating phosphodiesterase. CALP1 also binds to cytoplasmic si...

CAS 60142-95-2 Gabapentin hydrochloride

Gabapentin hydrochloride
(CAS: 60142-95-2)

Gabapentin HCl is a GABA analogue.Originally it was developed to treat epilepsy, and is currently used to relieve neuropathic pain and restless leg syndrome.

UK-1745
(CAS: 170684-14-7)

UK-1745, an indole derivative, has been found to be a Calcium channel antagonist that was once studied in the treatment of arrhythmias as well as heart failure.

CAS 13636-18-5 Fendiline hydrochloride

Fendiline hydrochloride
(CAS: 13636-18-5)

The hydrochloride salt form of Fendiline, a benzenepropanamine derivative, has been found to be a calcium channel blocker and alpha2-adrenergic receptor antagon...

CAS 1137264-00-6 cis-Ned 19

cis-Ned 19
(CAS: 1137264-00-6)

cis-Ned 19 is a irreversible nicotinic acid adenine dinucleotide phosphate (NAADP) antagonist, which inhibits Ca2+ release (IC50 = 800 nM) and [32P]NAADP bindin...

Chemical Structure

CAS 122647-32-9 Ibutilide Fumarate

Quick Inquiry

Verification code

Featured Items